Chronic myeloid leukemia (CML) is a malignant disorder in the hematopoietic stem cell, characterized by the emergence of the BCR/ABL1 (BA) fusion gene from chromosomal translocation t(9;22)(q34;q11) [180]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.